-
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
12 Jan 2026 13:36 GMT
… Health pancreatic cancer clinical trial begins
2027: Begin … study, as all clinical trials, subject to appropriate … Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical … cytarabine, also referred to as “Ara-C”) and, for the treatment …
-
Simultaneous Determination of Venetoclax and Posaconazole in Human Plasma by UPLC-MS/MS: Application to Therapeutic Drug Monitoring in Acute Myeloid Leukemia Patients
12 Jan 2026 04:27 GMT
… obtained from Nanjing XiZe Biotechnology Co., Ltd. ( … medications, varied from those in Agarwal’s study, potentially influencing drug … trial of decitabine vs treatment choice of supportive care or cytarabine … acute myeloid leukemia. Pharmaceutics. 2023;15(6 …
-
Garlic-Based Therapies: New Advances in AML Treatment
26 Dec 2025 15:23 GMT
… AML cells to cytarabine and daunorubicin, … for extensive clinical trials to validate safety … between natural remedies and scientific medicine, suggesting … traditional medicinegarlic-based cancer therapiesinnovative leukemia treatment strategiesmodulation …
-
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
15 Dec 2025 17:39 GMT
… -care agents such as cytarabine (Ara-C) and … with venetoclax, a standard treatment for AML. Intellectual … Medicines Agency (EMA) and the US Food and Drug Administration (FDA). This orphan drug … AB Science is a pharmaceutical company specializing in the …
-
AB Science annonce une nouvelle publication sur biorxiv identifiant AB8939 comme un candidat médicament prometteur pour le traitement de la leucémie myéloïde aiguë réfractaire et potentiellement d'autres cancers
15 Dec 2025 17:39 GMT
… as a drug candidate for the treatment of refractory … référence tels que la cytarabine (Ara-C) et … Food and Drug Administration (FDA) américaine. Cette désignation de médicament orphelin … Science est une société pharmaceutique spécialisée dans la recherche, …
-
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
09 Dec 2025 13:07 GMT
… Orphan Drug Designation from the FDA for the treatment of … Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical … 3 trial evaluating Annamycin in combination with cytarabine, together … to conduct its clinical trials as described in …
-
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile
09 Dec 2025 12:00 GMT
… ”), a clinical-stage biotechnology company developing next-generation … standard of care treatment
This safety profile … including Ara-C (cytarabine), and most had … Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Regenerative Medicine …
-
Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
06 Dec 2025 14:58 GMT
… controlled clinical trials are warranted … Zhongguancun Precision Medicine Science and Technology … Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab … treatment of central nervous system lymphoma: a retrospective study. Invest New Drugs …
-
<![CDATA[What Adverse Effects May Occur During Acute Myeloid Leukemia Treatment?]]>
02 Dec 2025 09:37 GMT
… with AML might experience during treatment, Peters, an assistant … the Department of Medicine at the Medical College of Georgia … is an anthracycline along with cytarabine. These are the [adverse … Going down the lower intensity treatment pathway, the standard of …
-
A new generation of AML treatments brings hope for better survival
02 Dec 2025 02:20 GMT
… Medicine, the updated 2025 American Society of Hematology (ASH) AML treatment … have led to FDA approval of three drugs to treat … hard questions that patients and doctors ask, and I… decitabine) or low-dose cytarabine. These treatments can be combined with …